Capitalmind Investec has advised the shareholder of Ortholab on the 100% sale to Excent Tandtechniek, backed by Oakley Capital.

About the deal

Ortholab, established in 1967, is a group of renowned orthodontic laboratories that provides high-quality technical work and services to orthodontists. With focus on innovation and excellence, Ortholab has established a strong reputation in the orthodontic field. Employing experienced technicians, the company produces advanced orthodontic appliances and retainers using state-of-the-art technology, including 3D printing, to achieve precise teeth alignment.

Owner and director of Ortholab, Roelant Seijger, will remain responsible for the management of the orthodontic laboratories after the acquisition.

With this transaction, Excent Tandtechniek continues the execution of its ambitious growth strategy, driven by organic growth, international expansion and targeted M&A.

What we did

Capitalmind Investec advised the shareholders of Ortholab throughout the sell-side process, with:

  • Managing price negotiations
  • Handling due diligence
  • Coordinating legal documentation phase
Target Headquarter
April 2024